Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Benz

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Cancer Research|January 15, 1989
Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancerC F Rochlitz, G K Scott, J M Dodson, et al.
The Journal of Biological Chemistry|May 20, 2000
Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamidesS Y Chiang, R W Burli, C C Benz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assayP Eng Tan, C C Benz, C Dollbaum, et al.
Cancer Research|September 1, 1997
Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumorsS R Johnston, B Lu, M Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Investigational New Drugs|January 1, 1995
Developing gossypol derivatives with enhanced antitumor activityX S Liang, A J Rogers, C L Webber, et al.
Cancer|June 15, 1993
Tumor labeling indices of primary breast cancers and their regional lymph node metastasesW H Goodson, B M Ljung, D H Moore, et al.
Breast Cancer Research and Treatment|January 1, 1993
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuC C Benz, G K Scott, J C Sarup, et al.
Oncogene|February 15, 2001
Ets regulation of the erbB2 promoterG K Scott, C H Chang, K M Erny, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Tumor targeting using anti-her2 immunoliposomesJ W Park, D B Kirpotin, K Hong, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cancer Research|January 15, 1989
Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancerC F Rochlitz, G K Scott, J M Dodson, et al.
The Journal of Biological Chemistry|May 20, 2000
Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamidesS Y Chiang, R W Burli, C C Benz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assayP Eng Tan, C C Benz, C Dollbaum, et al.
Cancer Research|September 1, 1997
Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumorsS R Johnston, B Lu, M Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Investigational New Drugs|January 1, 1995
Developing gossypol derivatives with enhanced antitumor activityX S Liang, A J Rogers, C L Webber, et al.
Cancer|June 15, 1993
Tumor labeling indices of primary breast cancers and their regional lymph node metastasesW H Goodson, B M Ljung, D H Moore, et al.
Breast Cancer Research and Treatment|January 1, 1993
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuC C Benz, G K Scott, J C Sarup, et al.
Oncogene|February 15, 2001
Ets regulation of the erbB2 promoterG K Scott, C H Chang, K M Erny, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Tumor targeting using anti-her2 immunoliposomesJ W Park, D B Kirpotin, K Hong, et al.
Pageof 8